Ekso Bionics Holdings, Inc.
EKSO

$22.19 M
Marketcap
$1.03
Share price
Country
$-0.02
Change (1 day)
$3.13
Year High
$0.75
Year Low

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. The company operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. It also provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; and EksoUE is a wearable upper extremity assistive device that helps to reduce the effect of gravity on the wearer's shoulders and arms. Ekso Bionics Holdings, Inc. has a license agreement with Lockheed Martin Corporation. The company was incorporated in 2005 and is headquartered in Richmond, California.

marketcap

Earnings for Ekso Bionics Holdings, Inc. (EKSO)

Earnings in 2023 (TTM): $-15,198,000

According to Ekso Bionics Holdings, Inc.'s latest financial reports the company's current earnings (TTM) are $-15,198,000. The earnings displayed on this page is the company's Pretax Income.

Earnings history of Ekso Bionics Holdings, Inc.

Annual Earnings

Year Income Before Tax Net Income
2023 $-15,198,000 $-15,198,000
2022 $-15,080,000 $-14,604,000
2021 $-9,764,000 $-8,432,000
2020 $-15,825,000 $-16,954,000
2019 $-12,132,000 $-11,694,000
2018 $-26,992,000 $-26,992,000
2017 $-29,122,000 $-29,122,000
2016 $-23,470,000 $-23,470,000
2015 $-19,590,000 $-19,590,000
2014 $-33,769,000 $-33,769,000
2013 $-12,292 $-12,292
2012 $-15,042,000 $-15,042,000